Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry (SWISS)
Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry (SWISS)
Sponsor: Cantonal Hospital of St. Gallen
Listed as NCT00811538, this observational or N/A phase trial focuses on Ischemic Stroke and remains completed. Sponsored by Cantonal Hospital of St. Gallen, it has been updated 7 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jul 2023 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Dec 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cantonal Hospital of St. Gallen
- Insel Gruppe AG, University Hospital Bern
- Kantonsspital Aarau
- Swiss Heart Foundation
- Triemli Hospital
- University Hospital, Basel, Switzerland
- University Hospital, Geneva
- University of Lausanne Hospitals
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .